Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Intestinal TG3- and TG2-Specific Plasma Cell Responses in Dermatitis Herpetiformis Patients Undergoing a Gluten Challenge.

Sankari H, Hietikko M, Kurppa K, Kaukinen K, Mansikka E, Huhtala H, Laurila K, Reunala T, Hervonen K, Salmi T, Lindfors K.

Nutrients. 2020 Feb 13;12(2). pii: E467. doi: 10.3390/nu12020467.

2.

Current Concepts of Dermatitis Herpetiformis.

Salmi T, Hervonen K.

Acta Derm Venereol. 2020 Feb 12;100(5):adv00056. doi: 10.2340/00015555-3401.

3.

Gliadin-Induced Ex Vivo T-Cell Response in Dermatitis Herpetiformis: A Predictor of Clinical Relapse on Gluten Challenge?

Kalliokoski S, Mansikka E, de Kauwe A, Huhtala H, Saavalainen P, Kurppa K, Hervonen K, Reunala T, Kaukinen K, Salmi T, Lindfors K.

J Invest Dermatol. 2020 Feb 7. pii: S0022-202X(20)30138-X. doi: 10.1016/j.jid.2019.12.038. [Epub ahead of print] No abstract available.

PMID:
32035923
4.

Risk of fractures in dermatitis herpetiformis and coeliac disease: a register-based study.

Pasternack C, Koskinen I, Hervonen K, Kaukinen K, Järvelin J, Reunala T, Collin P, Huhtala H, Mattila VM, Salmi T.

Scand J Gastroenterol. 2019 Jul;54(7):843-848. doi: 10.1080/00365521.2019.1636132. Epub 2019 Jul 7.

PMID:
31280614
5.

Gluten Challenge Induces Skin and Small Bowel Relapse in Long-Term Gluten-Free Diet-Treated Dermatitis Herpetiformis.

Mansikka E, Hervonen K, Kaukinen K, Ilus T, Oksanen P, Lindfors K, Laurila K, Hietikko M, Taavela J, Jernman J, Saavalainen P, Reunala T, Salmi T.

J Invest Dermatol. 2019 Oct;139(10):2108-2114. doi: 10.1016/j.jid.2019.03.1150. Epub 2019 Apr 15.

6.

Prognosis of Dermatitis Herpetiformis Patients with and without Villous Atrophy at Diagnosis.

Mansikka E, Hervonen K, Kaukinen K, Collin P, Huhtala H, Reunala T, Salmi T.

Nutrients. 2018 May 19;10(5). pii: E641. doi: 10.3390/nu10050641.

7.

Dermatitis Herpetiformis: A Common Extraintestinal Manifestation of Coeliac Disease.

Reunala T, Salmi TT, Hervonen K, Kaukinen K, Collin P.

Nutrients. 2018 May 12;10(5). pii: E602. doi: 10.3390/nu10050602. Review.

8.

Self-Reported Fractures in Dermatitis Herpetiformis Compared to Coeliac Disease.

Pasternack C, Mansikka E, Kaukinen K, Hervonen K, Reunala T, Collin P, Huhtala H, Mattila VM, Salmi T.

Nutrients. 2018 Mar 14;10(3). pii: E351. doi: 10.3390/nu10030351.

9.

Ex vivo Culture of Duodenal Biopsies from Patients with Dermatitis Herpetiformis Indicates that Transglutaminase 3 Antibody Production Occurs in the Gut.

Hietikko M, Hervonen K, Ilus T, Salmi T, Huhtala H, Laurila K, Rauhavirta T, Reunala T, Kaukinen K, Lindfors K.

Acta Derm Venereol. 2018 Mar 13;98(3):366-372. doi: 10.2340/00015555-2849.

10.

Diagnostic Delay in Dermatitis Herpetiformis in a High-prevalence Area.

Mansikka E, Salmi T, Kaukinen K, Collin P, Huhtala H, Reunala T, Hervonen K.

Acta Derm Venereol. 2018 Feb 7;98(2):195-199. doi: 10.2340/00015555-2818.

11.

Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease.

Collin P, Salmi TT, Hervonen K, Kaukinen K, Reunala T.

Ann Med. 2017 Feb;49(1):23-31. doi: 10.1080/07853890.2016.1222450. Epub 2016 Dec 14. Review.

PMID:
27499257
12.

Gastrointestinal Symptoms Increase the Burden of Illness in Dermatitis Herpetiformis: A Prospective Study.

Pasternack C, Kaukinen K, Kurppa K, Mäki M, Collin P, Hervonen K, Reunala T, Huhtala H, Kekkonen L, Salmi T.

Acta Derm Venereol. 2017 Jan 4;97(1):58-62. doi: 10.2340/00015555-2471.

13.

The Decreasing Prevalence of Severe Villous Atrophy in Dermatitis Herpetiformis: A 45-Year Experience in 393 Patients.

Mansikka E, Hervonen K, Salmi TT, Kautiainen H, Kaukinen K, Collin P, Reunala T.

J Clin Gastroenterol. 2017 Mar;51(3):235-239. doi: 10.1097/MCG.0000000000000533.

PMID:
27136959
14.

Serum transglutaminase 3 antibodies correlate with age at celiac disease diagnosis.

Salmi TT, Kurppa K, Hervonen K, Laurila K, Collin P, Huhtala H, Saavalainen P, Sievänen H, Reunala T, Kaukinen K.

Dig Liver Dis. 2016 Jun;48(6):632-7. doi: 10.1016/j.dld.2016.03.003. Epub 2016 Mar 9.

PMID:
27026081
15.

Dermatitis Herpetiformis Refractory to Gluten-free Dietary Treatment.

Hervonen K, Salmi TT, Ilus T, Paasikivi K, Vornanen M, Laurila K, Lindfors K, Viiri K, Saavalainen P, Collin P, Kaukinen K, Reunala T.

Acta Derm Venereol. 2016 Jan;96(1):82-6. doi: 10.2340/00015555-2184.

16.

Dermatitis herpetiformis: pathognomonic transglutaminase IgA deposits in the skin and excellent prognosis on a gluten-free diet.

Reunala T, Salmi TT, Hervonen K.

Acta Derm Venereol. 2015 Nov;95(8):917-22. doi: 10.2340/00015555-2162. Review.

17.

Celiac disease evolving into dermatitis herpetiformis in patients adhering to normal or gluten-free diet.

Salmi TT, Hervonen K, Kurppa K, Collin P, Kaukinen K, Reunala T.

Scand J Gastroenterol. 2015 Apr;50(4):387-92. doi: 10.3109/00365521.2014.974204. Epub 2015 Feb 1.

PMID:
25639558
18.

Small bowel transglutaminase 2-specific IgA deposits in dermatitis herpetiformis.

Salmi TT, Hervonen K, Laurila K, Collin P, Mäki M, Koskinen O, Huhtala H, Kaukinen K, Reunala T.

Acta Derm Venereol. 2014 Jul;94(4):393-7. doi: 10.2340/00015555-1764.

19.

Chronic gastritis in dermatitis herpetiformis: a controlled study.

Alakoski A, Salmi TT, Hervonen K, Kautiainen H, Salo M, Kaukinen K, Reunala T, Collin P.

Clin Dev Immunol. 2012;2012:640630. doi: 10.1155/2012/640630. Epub 2012 Apr 26.

20.

[Update on Current Care guidelines: coeliac disease].

Suomalaisen Lääkäriseuran Duodecimin; Suomen Gastroenterologiayhdistys RY:N Asettama Työryhmä.

Duodecim. 2011;127(3):296-7. Review. Finnish.

PMID:
21438352

Supplemental Content

Loading ...
Support Center